China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.83−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $2.71MP/E –Yield –
China SXT Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2026 it was -$7.12M. The highest annual figure on record is $1.77M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$7.12M | – |
| FY2025 | Mar 31, 2025 | -$2.68M | – |
| FY2024 | Mar 31, 2024 | -$2.52M | – |
| FY2023 | Mar 31, 2023 | -$5.61M | – |
| FY2022 | Mar 31, 2022 | -$5.19M | – |
| FY2021 | Mar 31, 2021 | -$2.20M | – |
| FY2020 | Mar 31, 2020 | -$1.34M | -175.8% |
| FY2019 | Mar 31, 2019 | $1.77M | +8.4% |
| FY2018 | Mar 31, 2018 | $1.63M | +1.9% |
| FY2017 | Mar 31, 2017 | $1.60M | – |
See a number that looks wrong?